Oral Mesalamine (Asacol) for Mildly to Moderately Active Ulcerative Colitis

Coated Oral 5-Aminosalicylic Acid Therapy for Mildly to Moderately Active Ulcerative Colitis

1987 • 2,734 citations

AN EXPERIMENT TO DETERMINE THE ACTIVE THERAPEUTIC MOIETY OF SULPHASALAZINE

1977 • 815 citations

5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis

1987 • 678 citations

Adverse Reactions during Salicylazosulfapyridine Therapy and the Relation with Drug Metabolism and Acetylator Phenotype

1973 • 451 citations

The role of intestinal bacteria in the metabolism of salicylazosulfapyridine.

1972 • 415 citations

Effect of sulphapyridine, 5-aminosalicylic acid, and placebo in patients with idiopathic proctitis: a study to determine the active therapeutic moiety of sulphasalazine.

1980 • 327 citations

Therapeutic Efficacy of Sulfasalazine and Its Metabolites in Patients with Ulcerative Colitis and Crohn's Disease

1980 • 318 citations

TREATMENT OF ULCERATIVE COLITIS WITH HIGH-DOSE 5-AMINOSALICYLIC ACID ENEMAS

1981 • 253 citations

Sulfasalazine

1983 • 241 citations

5-Aminosalicylic Acid in a Slow-Release Preparation: Bioavailability, Plasma Level, and Excretion in Humans

1982 • 221 citations

Comparison of delayed release 5 aminosalicylic acid (mesalazine) and sulphasalazine in the treatment of mild to moderate ulcerative colitis relapse.

1988 • 193 citations

Comparison of delayed-release 5-aminosalicylic acid (mesalazine) and sulfasalazine as maintenance treatment for patients with ulcerative colitis

1988 • 176 citations

The metabolism of salicylazosulphapyridine in ulcerative colitis: I The relationship between metabolites and the response to treatment in inpatients

1973 • 165 citations

Distribution and metabolism in healthy volunteers of disodium azodisalicylate, a potential therapeutic agent for ulcerative colitis.

1982 • 152 citations

Kinetics of 5‐aminosalicylic acid after jejunal instillation in man.

1983 • 136 citations

Maintenance of remission in ulcerative colitis with oral preparation of 5-aminosalicylic acid.

1982 • 127 citations

Colonic release of 5‐amino salicylic acid from an oral preparation in active ulcerative colitis.

1983 • 115 citations

Acetylator phenotype and adverse effects of sulphasalazine in healthy subjects

1972 • 104 citations

Clinical Experience of the Tolerance of Mesalazine and Olsalazine in Patients Intolerant of Sulphasalazine

1987 • 100 citations

Advances in Drug Therapy for Inflammatory Bowel Disease

1990 • 97 citations

Sulfasalazine-Induced Exacerbation of Ulcerative Colitis

1982 • 90 citations

The value of 5-aminosalicylic acid in inflammatory bowel disease for patients intolerant or allergic to sulphasalazine

1985 • 32 citations